Additionally, PARPi downregulates nucleolar RNA helicase II (DDX21) and inhibits ribosomal DNA transcription and ribosome biogenesis in BRCA1/2-proficient BC, ultimately resulting in decreased cell growth [66]. Here, BRCA1 is linked to breast cancer.